BOSTON DR LIM

BIOTECH (137) Nogra Pharma: Mongersen – Oral SMAD7 Antisense Oligonucleotide

March 15, 2024March 15, 2024

BIOTECH (136) Latigo Biotherapeutics: Non-Opioid Pain Medicine – Nav1.8 Antagonist LTG-001

March 15, 2024March 15, 2024

BIOTECH (135) Ionis Pharmaceuticals: ION224 (Ionis-DGAT2rx) for MASH Phase 2 Result

March 14, 2024March 14, 2024

BIOTECH (134) Madrigal Pharmaceuticals: The First MASH Drug Rezdiffra (Resmetirom) Got FDA Approval.

March 14, 2024March 14, 2024

BIOTECH (133) Geron’s The First Telomerase Oligonucleotide Inhibitor, Imeltestat, Near FDA Approval

March 14, 2024March 14, 2024

BIOTECH (132) GRO Biosciences: Genomically Recorded Organisms

March 13, 2024March 13, 2024

BIOTECH (131) Pearl Bio: Genomically Recorded Organisms with Synthetic Codons

March 13, 2024March 13, 2024

BIOTECH (130) Atlas Ventures: Option-to-Buy M&A Model – Nimbus Discovery & IFM Therapeutics

March 13, 2024March 13, 2024

부러우면 지는거다 (33) 편정현 헤드헌터 – 자리잡자

March 13, 2024July 6, 2025

BIOTECH (129) VLP Therapeutics: Self-Amplifying mRNA in Virus-Like Particle

March 12, 2024March 13, 2024